ReviewSmart molecules : open access2024
Positional functionalizations of metal-organic frameworks through invasive ligand exchange and additory MOF-on-MOF strategies: A review.
Review in Smart molecules : open access, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- MOF-on-MOF heterostructured composites for food safety analysis: construction strategies, sensing applications and sample pretreatment.RSC advances · 2026Review
- Cellulosic Composites in Lithium Metal Batteries.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Near infrared enhanced palladium loaded siraitia grosvenorii carbon dots amplify mitophagy for acute lung injury immunotherapy.Bioactive materials · 2026Article
- A general and green approach of pH-sensitive ZIF-67 for encapsulating active substances.Smart molecules : open access · 2026Article
- Design strategies for dual-atom and multi-atom catalysts: Unlocking synergistic interactions in carbon-based electrocatalysis.Fundamental research · 2026Review
- Structural Control of Photoconductivity in a Flexible Titanium-Organic Framework.Advanced materials (Deerfield Beach, Fla.) · 2025Article
- Red blood cell-activated antifreeze metal-organic framework armor for cryopreservation.Materials today. Bio · 2025Article
- Article
- Metal-organic frameworks (MOFs) for arsenic remediation: a brief overview of recent progress.RSC advances · 2025Review
- A NiNature communications · 2024Article
- Positional functionalizations of metal-organic frameworks through invasive ligand exchange and additory MOF-on-MOF strategies: A review.Smart molecules : open access · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal-organic frameworks (MOFs) represent a unique class of porous materials with tremendous potential for diverse applications. A key factor contributing to their versatility is their ability to precisely introduce functional groups at specific positions within pores and crystals. This review explores two prominent strategies for achieving the positional functionalization of MOFs: post-synthetic ligand exchange (PSE) and MOF-on-MOF. In PSE, the existing ligands within solid-state MOFs can be selectively replaced by the desired functional groups in solution through ligand dynamics. This invasive functionalization provides a flexible approach to fine-tuning the surface of the MOFs with the target functionality. Conversely, MOF-on-MOF strategies are additive methodologies involving the controlled growth of one MOF layer onto another. The functionality of the core and shell (or surface) can be independently controlled. This review critically examines the examples, strengths, limitations, and applications of these strategies, emphasizing their significance in advancing the field of MOF functionalization and paving the way for tailored multifunctional materials with precise and specific properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.